** Shares of healthcare services provider Evolent Health EVH.N fall 41.21% to $14.45
** Co cuts annual revenue forecast to be in the range of ~$2.55 billion to $2.58 billion, down from previous forecast of ~$2.56 billion to $2.60 billion
** Expects annual adjusted core profit to be between ~$160 million to $175 million vs about $230 million to $245 million previously expected
** Q3 rev. of $621.4 million misses est. of $627.15 million -LSEG
** Posts Q3 adj. core profit of $31.8 mln vs est. of $62.7 mln, impacted by elevated medical costs
** Stock down ~56% YTD
(Reporting by Sriparna Roy in Bengaluru)
((Sriparna.Roy@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。